Sheehan's syndrome
panhypopitarismus postpartualis latin

Sheehan's syndrome is occasionally caused by severe blood loss after delivering a baby.

Others regard Sheehan's syndrome as a form of pituitary apoplexy.

Sheehan's syndrome results from severe bleeding (hemorrhaging) immediately after giving birth.

It is commonly associated with Sheehan's syndrome, following post partum haemorrhage.

Rare conditions such as hemochromatosis, sarcoidosis, or Sheehan's syndrome (hypopituitarism).

Some medical conditions may occur in the postpartum period, such as Sheehan's syndrome and peripartum cardiomyopathy.

Rare sequelae include Hypopituitarism Sheehan's syndrome.

A rare hormonal disorder called Sheehan's syndrome makes a woman unable to produce milk or to produce enough milk to feed her baby.

In Sheehan's syndrome of postpartum hypopituitarism, the anterior pituitary uniformly malfunctions and underproduces all hormones.

Most common initial symptoms of Sheehan's syndrome are agalactorrhea (absence of lactation) and/or difficulties with lactation.

He was the first Canadian doctor to publicize Sheehan's syndrome, and the first North American to report on Simmond's disease.

A rarer reason is Sheehan's syndrome, also known as postpartum hypopituitarism, which is associated with prolactin deficiency; this syndrome may require hormone replacement.

Pituitary necrosis following postpartum haemorrhage (Sheehan's syndrome) leads to failure and atrophy of the gonads, adrenal and thyroid.

A 1995 study found that 56.2% of patients with Sheehan's syndrome experienced a loss of all pituitary hormones (with the remaining 43.8% having selective pituitary insufficiency).

Pituitary apoplexy is regarded by some as distinct from Sheehan's syndrome, where the pituitary undergoes infarction as a result of prolonged very low blood pressure, particularly when caused by bleeding after childbirth.

In a study of 1034 symptomatic adults, Sheehan's syndrome was found to be the sixth most frequent etiology of growth hormone deficiency, being responsible for 3.1% of cases (versus 53.9% due to a pituitary tumor).